It is normal for new mothers to be at risk for a blood clot for six weeks after giving birth. However, a new study suggests that women may still be at risk after those first six weeks.

Chemotherapy is a standard treatment for the most common form of leukemia — chronic lymphocytic leukemia (CLL). A combination of pills may offer CLL patients new, better and gentler options.

The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.

Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.

Diverticulosis — the presence of small pockets in the walls of the colon — is a very common digestive condition among older people. Researchers recently explored if diverticular diseases raised risks for cardiovascular disease.

A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.

Many leukemias can be treated successfully, but if the disease doesn’t respond, patients are left with few options. A new therapy may change all that.

Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.

While leukemia treatments can be uncomfortable, they also save lives. Still, reducing the discomfort of these treatments remains important, especially for the youngest patients.

Age can impact a patient’s treatment options, but when it comes to stem cell transplants, a recent study showed that being old may not be something to be worry about.